Data from large adverse event reporting systems suggest that women may report more side effects from antidiabetic drugs (like Ozempic), but the exact mechanisms are not fully understood
Patients with a history of pancreatitis should be monitored closely, and alternative therapies may be considered
Clinical data suggests 2040% of GLP-1 users experience digestive complaints ranging from mild bloating to moderate nausea, with indigestion occurring most commonly during dose escalation or in the first 48 weeks of treatment
Randevu almak iin ne yapmalym
Title: Indian pharma companies launch generic semaglutide injections for diabetes Source: Lokmat Times Link: 4
The exact schedule depends on the product label, the indication, prior exposure, missed doses, and clinician judgment